|
業務類別
|
Diagnostics & Research |
|
業務概覽
|
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services. |
| 公司地址
| 251 Ballardvale Street, Wilmington, MA, USA, 01887 |
| 電話號碼
| +1 781 222-6000 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.criver.com |
| 員工數量
| 19700 |
| Mr. Mark Mintz |
Corporate Executive Vice President and Chief Information Officer & Global Shared Services |
-- |
18/02/2026 |
| Ms. Birgit Girshick |
Chief Operating Officer and Director |
美元 742.49K |
09/01/2026 |
| Mr. Joseph W. LaPlume |
Corporate Executive Vice President, Corporate Development and Strategy |
美元 557.98K |
18/02/2026 |
| Ms. Shannon M. Parisotto |
Corporate Executive Vice President |
-- |
18/02/2026 |
| Mr. James C. Foster |
Chairman of the Board, President and Chief Executive Officer |
美元 1.51M |
09/01/2026 |
| Mr. Michael Gunnar Knell |
Interim Chief Financial Officer, Corporate Senior Vice President and Chief Accounting Officer |
-- |
18/02/2026 |
| Ms. Victoria L. Creamer |
Corporate Executive Vice President |
美元 541.90K |
18/02/2026 |
|
|
| Mr. Steven K. Barg |
Director |
18/02/2026 |
| Mr. Mark Joseph Enyedy |
Director |
18/02/2026 |
| Mr. Paul W. Graves |
Director |
18/02/2026 |
| Ms. Birgit Girshick |
Chief Operating Officer and Director |
09/01/2026 |
| Mr. George Llado, Sr |
Independent Director |
18/02/2026 |
| Ms. Reshema Kemps-Polanco |
Independent Director |
18/02/2026 |
| Mr. Abe Ceesay |
Director |
18/02/2026 |
| Mr. James C. Foster |
Chairman of the Board, President and Chief Executive Officer |
09/01/2026 |
| Dr. Martin W. Mackay, PhD |
Independent Director |
09/01/2026 |
| Dr. Nancy C. Andrews, M.D.,PhD |
Independent Director |
18/02/2026 |
| Dr. Craig B. Thompson,M.D. |
Independent Director |
18/02/2026 |
| Ms. Virginia M. Wilson |
Independent Director |
18/02/2026 |
|
|
|
|
